26 results
6-K
EX-1.1
ACIU
AC Immune SA
19 Dec 23
Current report (foreign)
8:53am
be expected to have a Material Adverse Effect.
(xlii) Healthcare Regulatory Compliance. Except as would not reasonably be expected to have a Material … or exclusion.
(xliii) Healthcare Product Manufacturing. The manufacture of the Company’s clinical products and product candidates by or on behalf
6-K
EX-99.2
ACIU
AC Immune SA
3 Nov 23
Current report (foreign)
7:30am
approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and by the Spanish Agency for Medicines and Health Products (AEMPS
6-K
EX-99.2
ACIU
AC Immune SA
4 Aug 23
Current report (foreign)
7:30am
and Healthcare Products Regulatory Agency (MHRA) and by the Spanish Agency for Medicines and Health Products (AEMPS) with the first patient dosed in Q2 2022
6-K
EX-99.2
ACIU
AC Immune SA
28 Apr 23
Current report (foreign)
7:30am
. The CTA has been approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and by the Spanish Agency for Medicines and Health
6-K
EX-99.1
c3l530g4 iu29flj
26 Sep 22
AC Immune Partner LMI Progresses Tau PET Tracer PI-2620 into Late-stage Development in Alzheimer’s Disease
9:07am
6-K
EX-99.1
0wfyvme5mv
29 Oct 21
AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika Bütler, Dr. oec., to its Board of Directors
4:35pm
6-K
EX-99.1
g5z wl8g98
7 Oct 21
Notice of the Extraordinary General Meeting (EGM) of 29 October 2021 To the Shareholders of AC Immune SA 1
7:27am
424B5
fl3gyqxracrcmim3pc
5 May 21
Prospectus supplement for primary offering
4:47pm
6-K
EX-99.3
itbaz77
5 Aug 20
Current report (foreign)
7:29am
6-K
EX-99.1
uz94tcy6mtscefv05n
26 Jun 20
Current report (foreign)
4:51pm
6-K
EX-99.1
njfmv12nptf mh3i9b
22 May 20
Invitation to the Ordinary Shareholders' Meeting
8:40am
6-K
EX-99.1
nmh22xl3 ub2lbgoh7ez
6 Nov 19
Current report (foreign)
6:48am
6-K
EX-99.1
a417c
28 Jun 19
Current report (foreign)
4:45pm
6-K
EX-99.1
k781a ehtg
4 Jun 19
Invitation to the Ordinary Shareholders' Meeting
7:22am
20-F/A
EX-4.14
hoqhv5 gvnjrvk1
19 Apr 19
Annual report (foreign) (amended)
5:07pm